Greta Preatoni, the innovative co-founder and CEO of Mynerva, discusses her groundbreaking work on a device designed to relieve neuropathic pain. She delves into the complexities of diabetic neuropathy and the risks associated with traditional opioid treatments. Greta shares insights on developing brain-computer interfaces and the importance of a strong patent strategy for MedTech startups. She also highlights the challenges of navigating health product regulations while emphasizing the potential of AI and electrical stimulation in improving patient care.